Geron Corporation (GERN) financial statements (2021 and earlier)

Company profile

Business Address 149 COMMONWEALTH DRIVE
MENLO PARK, CA 94025
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13913915215216316619
Cash and cash equivalents1421187111319
Short-term investments126118135145153154 
Restricted cash and investments0000000
Receivables1111111
Prepaid expense   3110
Other undisclosed current assets121   142
Total current assets:142142155156166169162
Noncurrent Assets
Operating lease, right-of-use asset20  
Property, plant and equipment0000000
Long-term investments and receivables20209181918 
Long-term investments20209181918 
Other noncurrent assets 111111
Other undisclosed noncurrent assets1 01  20
Total noncurrent assets:24221120191921
TOTAL ASSETS:166164166176185188183
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities141074533
Accounts payable1211100
Accrued liabilities8531111
Employee-related liabilities5332322
Debt00     
Other undisclosed current liabilities14123322
Total current liabilities:281296845
Noncurrent Liabilities
Long-term debt and lease obligation2      
Operating lease, liability2   
Total noncurrent liabilities:2      
Total liabilities:301296845
Stockholders' equity
Stockholders' equity attributable to parent135152157169178183178
Common stock0000000
Additional paid in capital1,2151,2031,1921,1911,1891,1881,177
Accumulated other comprehensive income (loss)0000(0)(0)(0)
Accumulated deficit(1,080)(1,051)(1,036)(1,022)(1,011)(1,004)(999)
Total stockholders' equity:135152157169178183178
TOTAL LIABILITIES AND EQUITY:166164166176185188183

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Gross profit:0000   
Operating expenses(30)(16)(15)(11)(10)(7)(7)
Other undisclosed operating income    000
Operating loss:(30)(16)(15)(11)(10)(7)(7)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
0(0)(0)(0)(0)(0)(0)
Loss before gain (loss) on sale of properties:(30)(16)(15)(11)(10)(7)(7)
Other undisclosed net income1  12  
Net loss:(29)(16)(15)(10)(7)(7)(7)
Other undisclosed net income attributable to parent 11  10
Net loss available to common stockholders, diluted:(29)(15)(14)(10)(7)(6)(7)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(29)(16)(15)(10)(7)(7)(7)
Other undisclosed comprehensive income0   0  
Comprehensive loss:(29)(16)(15)(10)(7)(7)(7)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)110(0)11
Comprehensive loss, net of tax, attributable to parent:(29)(15)(14)(10)(7)(6)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: